🟢 Conexeu Sciences is trading 7% up in pre-market with no verified company-specific catalyst identified

Conexeu Sciences is trading at $3.20, up 7.02%, amid broader biotech strength; no verified company-specific announcement explains the October 21 pre-market rise.

• Biotech ETF XBI was up 3.64% pre-market, supporting a sector-wide explanation rather than a confirmed company catalyst.
• The latest identified company release is the October 15 private placement.
• It raised approximately $5 million for working capital and development activities, but predates the move and does not establish its cause.